cobaltiprotoporphyrin has been researched along with Respiratory Distress Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G; Fang, M; Gong, FL; Gong, Q; Xiang, Y; Xiong, P; Yang, H; Yin, H; Yuan, CL; Zheng, F; Zheng, GY | 1 |
1 other study(ies) available for cobaltiprotoporphyrin and Respiratory Distress Syndrome
Article | Year |
---|---|
Heme oxygenase-1 upregulation significantly inhibits TNF-alpha and Hmgb1 releasing and attenuates lipopolysaccharide-induced acute lung injury in mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Heme Oxygenase-1; HMGB1 Protein; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Protoporphyrins; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |